AMANDA CURRY: Open Payments
NPI 1295405322 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 11 payments from 6 companies in 2025. Trend: 2023 $590 · 2024 $703 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $68 |
| Shionogi Inc | 3 | $64 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| ABBVIE INC. | 1 | $20 |
Products named: XIFAXAN, Fetroja, ZERBAXA, VPRIV, CAMZYOS, DALVANCE.
Industry payments across KY — which companies pay providers there.
